Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin Loading Effect on EPCs in ACS
NCT02957162Phase 4Completed
- Sponsor
- University Hospital of North Midlands
- Start
- Mar 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atorvastatin in acute coronary syndrome (ACS), sponsored by University Hospital of North Midlands. Primary endpoints: Number of Endothelial Progenitor Cells (EPCs) at 8 days, Number of EPCs in participants with different comorbid conditions at 8 days and 2 more. Started Mar 2016; status: completed.
02
Drugs
atorvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02957162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02957162.